Page 1,
Notes
Notes
1. Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative
disease. J. Clin. Investig. 2005;
115:1449-1457.
2. Griffin WS. Inflammation and neurodegenerative diseases. Am.
J. Clin. Nutr. 2006; 83:470S-474S.
3. Muravchick S, Levy RJ. Clinical implications of mitochondrial
dysfunction. Anesthesiology. 2006;
105:819-837.
4. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in
neurodegeneration: cause, effect or association? J.
Clin. Invest. 2003; 111:163-169.
5. Bonuccelli U, Del Dotto P. New pharmacologic horizons in the
treatment of Parkinson disease. Neurology.
2006; 67(Suppl 2):S30-S38.
6. Mattson MP. Infectious agents and age-related neurodegenerative
disorders. Ageing Res. Rev. 2004;
3:105-120.
7. Bazala E, Renda J. Latent Chlamydial infections: the probably
cause of a wide spectrum of human diseases. Med.
Hypotheses. 2005; 65:578-584.
8. Koch AL. Cell wall-deficient (CWD) bacterial pathogens: could
amyotrophic lateral sclerosis (ALS) be due to one? Crit.
Rev. Microbiol. 2003; 29:215-221.
9. Nicolson GL, Nasralla M, Franco AR, et al. Mycoplasmal infections
in fatigue illnesses: chronic fatigue and fibromyalgia syndromes,
Gulf War illness and rheumatoid arthritis.
J. Chronic Fatigue Syndr. 2000; 6(3/4):23-39.
10. Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections
detected in blood of chronic fatigue and fibromyalgia syndrome patients.
Eur. J. Clin. Microbiol. Infect. Dis.
1999; 18:859–65.
11. Nicolson GL, Nasralla M, Gan R, Haier J, De Meirleir K. Evidence
for bacterial (mycoplasma, Chlamydia) and viral (HHV-6) co-infections
in chronic fatigue syndrome patients. J.
Chronic Fatigue Syndr. 2003; 11(2):7-20.
12. Evans R, Mavin S, Ho-Yen DQ. Audit of the laboratory diagnosis
of Lyme disease in Scotland. J. Med. Microbiol.
2005; 54:1139-1141.
13. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison
of Western immunoblotting and C6 Lye antibody test for laboratory
detection of Lyme disease. Clin. Diagnost.
Lab. Immunol. 2004; 11:924-929.
14. Williams DB, Windebank AJ. Motor neuron disease (amyotrophic
lateral sclerosis). Mayo Clin. Proc.
1991; 66:54-82.
15. Swash M, Schwartz MS. What do we really know about amyotrophic
lateral sclerosis? J. Neurol. Sci.
1992; 113:4-16.
16. Walling AD. Amyotrophic lateral sclerosis: Lou Gehrig's disease.
Amer. Fam. Physician. 1999; 59:1489-1496.
17. Muir P, Nicholson F, Spencer GT, et al. Enterovirus infection
of the central nervous system of humans:
lack of association with chronic neurological disease. J.
Gen. Virol. 1996; 77:1469-1476.
18. Berger MM, Kopp N, Vital C, Redl B, Aymard M, Lina B. Detection
and cellular localization of enterovirus RNA sequences in spial
cord of patients with ALS. Neurology.
2000; 54:20-25.
19. Walker MP, Schlaberg R, Hays AP, Bowser R, Lipkin WI. Absence
of echovirus sequences in brain and spinal cord of amyotrophic lateral
sclerosis patients. Ann. Neurol. 2001;
49:249-253.
20. Nicolson GL, Berns P, Nasralla M, Haier J, Pomfret J. High frequency
of systemic mycoplasmal infections in Gulf War veterans and civilians
with amyotrophic lateral sclerosis (ALS). J.
Clin. Neurosci. 2002; 9:525-529.
21. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn
superoxide dismutase gene are associated with familial amyotrophic
lateral sclerosis. Nature. 1993;
362:59-62.
22. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport
by the brain and spinal cord in amyotrophic lateral sclerosis. N.
Engl. J. Med. 1992; 326:1464-1468.
23. Hugan J. ALS therapy: targets for the future. Neurology.
1996; 47(Suppl 4):S251-S254.
24. Sobel RA. The pathology of multiple sclerosis. Neurol.
Clin. 1995; 13:1-21.
25. Bruck W. Clinical implications of neuropathological findings
in multiple sclerosis. J. Neurol.
2005; 252(Suppl 3):10-14.
26. Gilden DH. Infectious casues of multiple sclerosis. Lancet
Neurol. 2005; 4:195-2002.
27. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, Mitchell
WM. Chlamydia pneumoniae infection of the central nervous system
in multiple sclerosis. Ann. Neurol.
1999; 46:6-14.
28. Stratton CW, Sriram S. Association of Chlamydia pneumoniae with
central nervous system disease. Microbes
Infect. 2003; 5:1249-1253.
29. Stratton CW, Wheldon DB. Multiple sclerosis: an infectious syndrome
involving Chlamydophia pneumoniae. Trends
Microbiol. 2006; 14:474-479.
30. Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Juttler E, Schnitzler
P, Grond-Ginsbach C, Grau AJ. Evidence for infection with Chlamydia
pneumoniae in a subgroup of patients with multiple sclerosis. Ann.
Neurol. 2000; 47:652-655.
31. Boman J, Roblin PM, Sundstrom P, Sandstrom M, Hammerschlag MR.
Failure to detect Chlamydia pneumoniae in central nervous system
of patients with MS. Neurology.
2000; 11:265.
32. Pucci E, Taus C, Cartechini E, Morelli M, Giuliani G, Clementi
M, Menzo S. Lack of Chlamydia infection of the central nervous system
in multiple sclerosis. Ann. Neurol.
2000; 48:399-400.
33. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents
and multiple sclerosis – Are Chlamydia pneumoniae and human
herpes virus 6 involved? J. Neuroimmunol.
2003; 136:1-8.
34. Steiner I, Nisipianu P, Wirguin I. Infection and etiology and
pathogenesis of multiple sclerosis. Curr.
Neurol. Neurosic. Rep. 2001; 1:271-6276.
35. Lo SC, Buchholz CL, Wear DJ, et al. Histopathology and doxycycline
treatment in a previously healthy non-AIDS patient systemically
infected by Mycoplasma fermentans (incognitus strain). Mod.
Pathol. 1991; 6:750-754.
36. Lo SC, Wear DJ, Shih WK, et al. Fatal systemic infections of
non-human primates by Mycoplasma fermentans (incognitus strain).
Clin. Infect. Dis. 1993; 17 (Suppl
1): S283-S288.
37. Keller JN. Age-related neuropathology, cognitive decline and
Alzheimer's disease. Ageing Res. Rev.
2006; 5:1-13.
38. Masters CL, Beyreuther K. Alzheimer's centennial legacy: prospects
for rational therapeutic intervention targeting the Abeta amyloid
pathway. Brain. 2006; 129:2823-2839.
39. Drachman DA. Aging of the brain, entropy, and Alzheimer disease.
Neurology. 2006; 67:1340-1352.
40. Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA and
RNA in mild cognitive impairment. Arch.
Neurol. 2007; 64:954-956.
41. Daly MP. Diagnosis and management of Alzheimer disease. J.
Am. Board Fam. Pract. 1999; 12:375-385.
42. Finch CE, Morgan TE. Systemic inflammation, infection, ApoE
alleles and Alzheimer disease: a position paper. Curr.
Alzheimer Res. 2007; 4:185-189.
43. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D,
Perry VH. Systemic infection, interleukin 1-beta and cognitive decline
in Alzheimer's disease. J. Neurol. Neurosurg.
Psychiatry. 2003; 74:788-789.
44. Dobson CB, Wozniak MA, Itzhaki RF. Do infectious agents play
a role in dementia? Trends Microbiol.
2003; 11:312-317.
45. Balin BJ, Appelt DM. Role of infection in Alzheimer's disease.
J. Am. Osteopath. Assoc. 2001; 101(Suppl
12):S1-S6.
46. Yucesan C, Sriram S. Chlamydia pneumoniae infection of the central
nervous system. Curr. Opin. Neurol.
2001: 14:355-359.
47. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, et al.
Identification and localization of Chlamydia pneumoniae in the Alzheimer's
brain. Med. Microbiol. Immunol.
1998; 187:23-42.
48. Gerard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C,
et al. Chlamydophila (Chlamydia) penumoniae in the Alzheimer's brain.
FEMS Immunol. Med. Microbiol. 2006;
48:355-366.
49. MacIntyre A, Abramov R, Hammond CJ, Hudson AP, et al. Chlamydia
pneumoniae infection promotes the transmigration of monocytes through
human brain endothelial cells. J. Neurosci.
Res. 2003; 71:740-750.
50. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia
pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c
mice. Neurobiol. Aging. 2004; 25:419-429.
51. Ring RH, Lyons JM. Failure to detect Chlaymdia pneumoniae in
the late-onset Alzheimer's brain. J. Clin.
Microbiol. 2000; 38:2591-2594.
52. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect
Chlamydia pneumoniae in brain sections of alzheimer's disease patients.
J. Clin. Microbiol. 2000; 38:881-882.
53. Meer-Scheerer L, Chang Loa C, Adelson ME, Mordechai E, Lobrinus
JA, Fallon BA, Tilton RC. Lyme disease associated with Alzheimer's
disease. Curr. Microbiol. 2006;
52:330-332.
54. Pappolla MA, Omar R, Saran B, Andorn A, Suarez M, et al. Concurent
neuroborreliosis and Alzheimer's disease: analysis of the evidence.
Hum. Pathol. 1989; 20:753-757.
55. MacDonald AB. Alzheimer's disease Braak Stage progressions:
reexamined and redefined as Borrelia infection transmission through
neural circuits. Med. Hypotheses.
2007; 68:1059-1064.
56. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle
L, Hurlimann J, Paster BJ. Borrelia burgdorferi persists in the
brain in chronic Lyme neuroborreliosis and may be associated with
Alzheimer's disease. J. Alzheimer's Dis.
2004; 6:639-649.
57. MacDonald AB. Plaques of Alzheimer's disease orginate from cysts
of Borrelia Burgdorferi, the Lyme disease spirochete.
Med. Hypotheses. 2006; 67:592-600.
58. Glabe C. Intracellular mechanisms of amyloid accumulation and
pathogenesis in Alzheimer's disease. J.
Mol. Neurosci. 2001; 17:137-135.
59. Marques AR, Weir SC, Fahle GA, Fischer SH. Lack of evidence
of Borrelia involvement in Alzheimer's disease. J.
Infect. Dis. 2000; 182:1006-1007.
60. Denaro FJ, Staub P, Colmer J, Freed DM. Coexistance of Alzheimer's
disease neuropathology with Herpes Simplex encephalitis. Cell
Mol. Biol. 2003; 49:1233-1240.
61. Lin WR, Shang D, Itzhaki RF. Neurotrophic viruses and Alzheimer's
disease. Interaction of Herpes Simplex type-1 virus and apolipoprotein
E in the etiology of the disease. Mol.
Chem. Neuropathol. 1996; 28:135-141.
62. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson
GA. Herpes Simplex Virus type 1 in brain and risk of Alzheimer's
disease. Lancet. 1997; 349:241-244.
63. Shipley SJ, Parkin ET, Itzhaki RF, Dobson CB. Herpes Simplex
virus interferes with amyloid precursor protein processing. BMC
Microbiol. 2005; 5:48.
64. Rimland B. The Autism epidemic, vaccinations and mercury. J.
Nut. Environ. Med. 2000; 10:261–266.
65. Downing D. Mercury again. J. Nut. Environ.
Med, 2000; 10:267–269.
66. Nicolson GL. Chronic infections as a common etiology for many
patients with chronic fatigue syndrome, fibromyalgia syndrome and
Gulf War Illnesses. Intern. J. Med.
1998; 1:42–46.
67. Nicolson GL, Nasralla M, Hier J, Erwin R, Nicolson NL. Mycoplasmal
infections in chronic illnesses: fibromyalgia and chronic fatigue
syndromes, Gulf War illness, HIV-AIDS and rheumatoid arthritis.
Med. Sentinel, 1999; 4:172–176.
68. Nicolson GL, Nasralla M, Franco AR, De Meirlier K, Nicolson
NL, Ngwenya R, Haier J. Mycoplasmal infections in fatigue illnesses:
chronic fatigue and fibromyalgia syndromes, Gulf War illness and
rheumatoid arthritis. J. Chronic Fatigue
Syndr. 2000; 6(3):23–39.
69. Thornton D. A survey of Mycoplasma detection in vaccines. Vaccine.
1986; 4:237–240.
70. Nicolson, GL, Nasralla MY, Nicolson NL, Haier J. High prevalence
of mycoplasmal infections in symptomatic (chronic fatigue syndrome)
family members of mycoplasma-positive Gulf War Illness patients.
J. Chronic Fatigue Syndr, 2003; 11(2):21-36.
71. Nicolson GL, Nicolson NL. Chronic fatigue illness and Operation
Desert Storm. J. Occup. Environ. Med.
1996; 38:14-16.
72. Nicolson GL, Nicolson NL. Diagnosis and treatment of mycoplasmal
infections in Persian Gulf War Illness-CFIDS patients.
Intern. J. Occup. Med. Immunol. Tox. 1996; 5:69–78.
73. Nicolson GL, Berns P, Gan R, Haier J. Chronic mycoplasmal infections
in Gulf War veterans' children and autism patients. Med.
Veritas. 2005; 2:383-387.
74. Nicolson GL, Nicolson NL, Nasralla M. Mycoplasmal infections
and Chronic Fatigue Illness (Gulf War Illness) associated with deployment
to Operation Desert Storm. Intern. J. Med,
1998; 1:80–92.
75. Nicolson GL, Gan R, Nicolson NL, Haier J. Evidence for Mycoplasma,
Chlamydia pneunomiae and HHV-6 Co-infections in the blood of patients
with autism spectrum disorders. J. Neuroscience
Res. 2007; 85:1143-1148.
76. Morrison JD. Fatigue as a presenting complaint in family practice.
J. Fam. Pract. 1980; 10:795-801.
77. Fukuda K, Strauss SE et al. The chronic fatigue syndrome, a
comprehensive approach to its definition and study. Ann.
Intern. Med. 1994; 121:953-959.
78. Wolfe F, Smythe HA, Yunus MB, et al. The American College of
Rheumatology 1990 Criteria for the classification of fibromyalgia.
Report of the Multicenter Criteria Committee. Arthritis
Rheum. 1990: 33:160-172.
79. Nicolson GL, Gan R, Haier J. Multiple co-infections (Mycoplasma,
Chlamydia, human herpesvirus-6) in blood of chronic fatigue syndrome
patients: association with signs and symptoms. Acta
Pathol. Microbiol. Immunol. Scand. 2003; 111:557-566.
80. Nicolson, G.L., Nicolson, N.L, Haier, J. Chronic fatigue syndrome
patients subsequently diagnosed with Lyme disease Borrelia burgdorferi:
evidence for Mycoplasma species co-infections. J.
Chronic Fatigue Syndr. 2008; in press.
81. Nicolson GL, Gan R, Haier J. Evidence for Brucella spp. and
Mycoplasma spp. co-Infections in blood of Chronic Fatigue Syndrome
patients. J. Chronic Fatigue Syndr. 2005;
12(2):5-17.
82. Burgdorfer WA, Barbour AG, Hayes SF, et al. Lyme disease –
a tick-borne spirochetosis? Science 1982;
216:1317-1319.
83. Kind A, Schned E, Anderson F, et al. Lyme disease guidelines
for Minnesota clinicians: epidemiology, microbiology, diagnosis,
treatment and prevention. Minnesota Department of Public Health,
1999.
84. Gale A, Ringdahl E. Tick-borne diseases. Amer.
Fam. Physician. 2001; 64:461-466.
85. Nicolson, G.L. Diagnosis and therapy of chronic systemic co-infections
in Lyme disease and other tick-borne infectious diseases. Townsend
Lett. 2007; 285:93-98.
86. Verdon ME, Sigal LH. Recognition and management of Lyme disease.
Amer. Fam. Physician. 1997; 56:427-436.
87. Klempner MS, et al. Intralaboratory reliability of serologic
and urine testing for Lyme disease. Amer.
J. Med. 2001: 110:217-219.
88. Eskow E, Adelson ME, Rao RV, Mordechai E. Evidence for disseminated
Mycoplasma fermentans in New Jersey residents with antecedent tick
attachment and subsequent musculoskeletal symptoms.
J. Clin. Rheumatol. 2003; 9:77-87.
89. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of
coinfection to tick-borne pathogens of babesiosis, ehrlichiosis
and Lyme borrelosis in human sera. J. Clin.
Microbiol. 1996; 34:724-727.
90. Belongia EA, Reed KD, Mitchell PD, et al. Clinical and epidemiological
features of early Lyme disease and human granulocytic ehrlichiosis
in Wisconsin. Clin. Infect. Dis.
1999; 29:1472-1477.
91. Eskow E, Rao R-V, Mordechai E. concurrent infection of the central
nervous system by Borrelia burgdorferi and Bartonella henselae.
Arch. Neurol. 2001; 58:1357-1363.
92. Armengol CE, Hendley JD. Cat-scratch disease encepthalopathy:
a cause of status epilepticus in school-aged children. J.
Pediatr. 1999; 134:635-638.
93. Mylonakis E. When to suspect and how to monitor Babesiosis.
Amer. Family Physican. 2001; 63:1969-1974.
94. Nicolson GL, Nasralla M, Franco AR, Nicolson NL, Erwin R, Ngwenya
R, Berns PA. Diagnosis and integrative treatment of intracellular
bacterial infections in Chronic Fatigue and Fibromyalgia Syndromes,
Gulf War Illness, Rheumatoid Arthritis and other chronic illnesses.
Clin. Pract. Alt. Med. 2000; 1(2):
92-102.
95. Nicolson GL, Ngwenya R. Dietary considerations for patients
with chronic illnesses and multiple chronic infections. A brief
outline of eighteen dietary steps to better health. Townsend
Lett. 2001; 219:62-65
96. Nicolson, G.L. Lipid replacement as an adjunct therapy in chronic
fatigue, anti-aging and restoration of mitochondrial function. J.
Am. Nutraceut. Assoc. 2003; 6(3): 22-28.
97. Nicolson, G.L. Lipid replacement and antioxidant supplements
to prevent membrane oxidation and restore mitochondrial function
in metabolic syndrome and fatiguing illnesses. Townsend
Lett. 2007; 286: 112-120
|